Table 4.
Patient and Treatment Characteristics in TNBC T1-2N0 Tumors Stratified by BCT and MRM
Characteristic | BCT |
MRM |
P | ||
---|---|---|---|---|---|
No. | % | No. | % | ||
Total patients | 233 | 49.8 | 235 | 50.2 | |
Age at diagnosis, years | .20 | ||||
Median | 53 | 55 | |||
Range | 26-83 | 27-89 | |||
Tumor grade | .72 | ||||
1-2 | 42 | 18.0 | 47 | 20.0 | |
3 | 191 | 82.0 | 188 | 80.0 | |
LVI | .73 | ||||
Negative | 186 | 80.0 | 183 | 78.0 | |
Positive | 47 | 20.0 | 52 | 22.0 | |
Adjuvant chemotherapy | .90 | ||||
No | 152 | 65.0 | 155 | 66.0 | |
Yes | 81 | 35.0 | 80 | 34.0 |
Abbreviations: BCT, breast-conserving therapy; MRM, modified radical mastectomy; LVI, lymph vascular invasion; TNBC, triple-negative breast cancer.